Fundraising Fox
Viking Therapeutics
NASDAQ: VKTXSan Diego, US · Founded 2012 · 2 known investors
Find your way into Viking Therapeutics
Sign up to see every warm intro you have to Viking Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Viking Therapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders. This page presents its board of directors.
Founders & leadership
Viking Therapeutics was founded in 2012 by Brian Lian.
MM
Michael MorneauChief Financial Officer
DL
Dr. LianPresident & Chief Executive Officer, Director
SW
Stephen W. WebsterNamed on SEC filing
MW
Matthew W. FoehrNamed on SEC filing
Board
JM
J. Matthew SingletonBoard director
LM
Lawson MacartneyBoard director
Investors · 2
Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
Ligand PharmaceuticalsreportedJupiter
How we know: the S-1 prospectus · Not right? Tell us
Reported raises · per SEC filings
Form D private placements▶$3.7MofferedJun 2017 · 10 investors · BiotechnologyRule 506(b)
▶$3.7MofferedJun 2017 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen W. WebsterDirector
- Matthew W. FoehrDirector
- J. Matthew SingletonDirector
- Lawson MacartneyDirector
- Michael MorneauExecutive Officer
- Brian LianExecutive Officer, Director
- Offering amount
- $3.7M
- Sales commissions
- $269.5K
- Finders' fees
- $30K
- Placement agents
- Roth Capital Partners, LLC, Maxim Group LLC
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$22.5Mvaluation at IPOApr 2016 · $1.24/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 6
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
TradingViewTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
StockTwitsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
TipRanksFinancial analysis and stock research platform.
Companies working in the same space as Viking Therapeutics.
Frequently asked questions
- What does Viking Therapeutics do?
- Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders. This page presents its board of directors.
- Who founded Viking Therapeutics?
- Viking Therapeutics was founded by Brian Lian in 2012.
- Who are Viking Therapeutics's investors?
- Viking Therapeutics's investors include Avoro Capital Advisors, Ligand Pharmaceuticals.
- Where is Viking Therapeutics headquartered?
- Viking Therapeutics is headquartered in San Diego, US.